SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017566
Filing Date
2022-11-14
Accepted
2022-11-14 07:21:18
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hook-20220930x10q.htm   iXBRL 10-Q 1709820
2 EX-31.1 hook-20220930xex31d1.htm EX-31.1 9859
3 EX-31.2 hook-20220930xex31d2.htm EX-31.2 9853
4 EX-32.1 hook-20220930xex32d1.htm EX-32.1 8345
  Complete submission text file 0001558370-22-017566.txt   6647867

Data Files

Seq Description Document Type Size
5 EX-101.SCH hook-20220930.xsd EX-101.SCH 54069
6 EX-101.CAL hook-20220930_cal.xml EX-101.CAL 50395
7 EX-101.DEF hook-20220930_def.xml EX-101.DEF 194285
8 EX-101.LAB hook-20220930_lab.xml EX-101.LAB 443931
9 EX-101.PRE hook-20220930_pre.xml EX-101.PRE 329741
62 EXTRACTED XBRL INSTANCE DOCUMENT hook-20220930x10q_htm.xml XML 1035343
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38869 | Film No.: 221380201
SIC: 2834 Pharmaceutical Preparations